677
To evaluate the long-term (up to 5 years exposure) safety and efficacy of lacosamide as adjunctive therapy in patients with uncontrolled partial-onset seizures taking one to three concomitant antiepileptic drugs (AEDs) in open-label extension trial SP756 (NCT00522275).
 long-term (up to 5 years exposure): Treatment; lacosamide as adjunctive therapy: Treatment; taking one to three concomitant antiepileptic drugs (AEDs): Treatment; uncontrolled partial-onset seizures: Treatment.Disorder; lacosamide: Treatment.Drug; antiepileptic drugs: Treatment.Drug; long-term (up to 5 years exposure): Treatment.Duration; lacosamide: Combination.Drug; antiepileptic drugs: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 long-term (up to 5 years exposure): Treatment; lacosamide as adjunctive therapy: Treatment; taking one to three concomitant antiepileptic drugs (AEDs): Treatment; uncontrolled partial-onset seizures: Treatment.Disorder; lacosamide: Treatment.Drug; antiepileptic drugs: Treatment.Drug; long-term (up to 5 years exposure): Treatment.Duration; lacosamide: Combination.Drug; antiepileptic drugs: Combination.Drug